Literature DB >> 16985936

Case reports on prostate cancer.

.   

Abstract

Entities:  

Year:  2004        PMID： 16985936      PMCID： PMC1472886     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  17 in total

1.  Early androgen deprivation for prostate cancer?

Authors:  M A Eisenberger; P C Walsh
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

Review 2.  Malignant spinal cord compression.

Authors:  Madhuri Yalamanchili; Glenn J Lesser
Journal:  Curr Treat Options Oncol       Date:  2003-12

3.  Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.

Authors:  E M Messing; J Manola; M Sarosdy; G Wilding; E D Crawford; D Trump
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

4.  Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.

Authors:  M W Kattan; T M Wheeler; P T Scardino
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

5.  A structured debate: immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment.

Authors:  P C Walsh; T L DeWeese; M A Eisenberger
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

6.  The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis.

Authors:  R K Valicenti; L G Gomella; M Ismail; S E Strup; S G Mulholland; A P Dicker; R O Petersen; C J Newschaffer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-08-01       Impact factor: 7.038

Review 7.  Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing radiation treatment for prostate cancer.

Authors:  Thomas M Pisansky
Journal:  Urology       Date:  2003-12-29       Impact factor: 2.649

Review 8.  Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer.

Authors:  Christopher J Diblasio; Michael W Kattan
Journal:  Urology       Date:  2003-12-29       Impact factor: 2.649

9.  An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists.

Authors:  Michael Koch; Christopher Steidle; Stanley Brosman; Arthur Centeno; Franklin Gaylis; Marilyn Campion; Marc B Garnick
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

10.  Treatment and prognosis of patients with paraplegia or quadriplegia because of metastatic spinal cord compression in prostate cancer.

Authors:  M Nagata; T Ueda; A Komiya; H Suzuki; K Akakura; M Ishihara; T Tobe; T Ichikawa; T Igarashi; H Ito
Journal:  Prostate Cancer Prostatic Dis       Date:  2003       Impact factor: 5.554
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.